BTX-A51 Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: (1r,4r)-N 1-(5-chloro-4-(5-(cyclopropylmethyl)-1-methyl-l H pyrazol-3-yl)pyrimidin-2-yl)cyclohexane-l ,4-diamine bis(4-methylbenzenesulfonate),, C32H41ClN6O6S2

Filter by location:

Duarte, California1 trial

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

City of Hope National Medical Center

Phase 1

Lake Mary, Florida1 trial

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Florida Cancer Specialists

Phase 1

Boston, Massachusetts1 trial

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Brigham and Women's Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.